We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Value explore and correlation analysis on pulmonary artery pressure and brain natriuretic peptide predicting prognosis in septic shock patients].
Zhonghua Yi Xue za Zhi [Chinese medical journal] 2015 July 22
OBJECTIVE: To evaluate and explore the relationship among the pulmonary artery pressure, Brain natriuretic peptide and the prognosis in the patients with septic shock.
METHODS: From May 2013 to Oct. 2014, 48 patients were treated with Swan-Ganz catheter to monitor the pulmonary artery pressure, the pulmonary vascular resistance, the pulmonary capillary wedge pressure and cardiac output. Testing brain natriuretic peptide, Analysising the differences between survival patients (27 cases) and dead patients (21 cases) in the PAP, PVR, PCWP, CO and BNP, Analysising the correlation between BNP and PAP, PVR, PCWP, CO by Linear correlation analysis.
RESULTS: It is no difference in hemodynamic parameters between dead patients and survival patients when they come in the hospital (P > 0.05); it is significant difference in hemodynamic parameters between dead patients and survival patients when they came in the hospital after 48 hours or 72 hours [(20.8 ± 5.8) mmHg vs (34.2 ± 7.4) mmHg, P < 0.05], it is no difference in PVR, PCWR and CO at 24 hours, 48 hours or 72 hours. Then it is significant difference in BNP between dead patients and survival patients that they had been entered the hospital after 48 hours or 72 hours [(286.5 ± 75.5) pg/ml vs (675.4 ± 51.3) pg/ml, P < 0.05], it has no obvious correlation among the BNP, PAP and CO.
CONCLUSIONS: It prompts a poor prognosis if the patients with septic shock had increased the pulmonary artery pressure and the BNP. Therefore it is need focus on pulmonary hypertension, it is different if BNP of plasma in heart failure patients increased, it does not mean heart function failuring, so it can not be used to give a guide to therapy on heart function.
METHODS: From May 2013 to Oct. 2014, 48 patients were treated with Swan-Ganz catheter to monitor the pulmonary artery pressure, the pulmonary vascular resistance, the pulmonary capillary wedge pressure and cardiac output. Testing brain natriuretic peptide, Analysising the differences between survival patients (27 cases) and dead patients (21 cases) in the PAP, PVR, PCWP, CO and BNP, Analysising the correlation between BNP and PAP, PVR, PCWP, CO by Linear correlation analysis.
RESULTS: It is no difference in hemodynamic parameters between dead patients and survival patients when they come in the hospital (P > 0.05); it is significant difference in hemodynamic parameters between dead patients and survival patients when they came in the hospital after 48 hours or 72 hours [(20.8 ± 5.8) mmHg vs (34.2 ± 7.4) mmHg, P < 0.05], it is no difference in PVR, PCWR and CO at 24 hours, 48 hours or 72 hours. Then it is significant difference in BNP between dead patients and survival patients that they had been entered the hospital after 48 hours or 72 hours [(286.5 ± 75.5) pg/ml vs (675.4 ± 51.3) pg/ml, P < 0.05], it has no obvious correlation among the BNP, PAP and CO.
CONCLUSIONS: It prompts a poor prognosis if the patients with septic shock had increased the pulmonary artery pressure and the BNP. Therefore it is need focus on pulmonary hypertension, it is different if BNP of plasma in heart failure patients increased, it does not mean heart function failuring, so it can not be used to give a guide to therapy on heart function.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app